Patients Reimagining VLU and DFU management: Why speed matters in chr... Chronic wounds, particularly venous leg ulcers (VLUs) and diabetic foot ulcers (DFUs), represent a persistent and growing challenge in healthcare.
News FDA clears Viridian's Tepezza rival for thyroid eye disease Viridian has fired a shot across Amgen's bows with the FDA approval of Tepezza rival Lumvoa in thyroid eye disease, a $2bn market.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.